- Mandhare MN, Patil PH, Jagdale DM, KadamVJ. Targeting matrix metalloproteinases: An
important strategy in cancer therapeutics. Int J Pharm Sci. 2012; 12: 27-39.
2. Radisky ES, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 2012; 15: 201-212.
3. Verma RP, Hansch C. Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)
SARs. Bioorg Med Chem. 2007; 15: 2223-2268.
4. Chung Tk, Moon SK. Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus
infection in liver cells. Arch Biochem Biophys. 2002; 408: 147-154.
5. Riley GP. (2005). Domain structure of matrix metalloproteinase (MMPs) and ADAMTS.
Retrieved from cambridge university press. Information website: https://www.researchgate.net/
figure/Domain-structure-of-matrix-metalloproteinases-MMPs-and-ADAMTS-a-MMPs-Thearchetypal_fig2_7938800.
6. Adabi Z, Mohsen Ziaei SA, Imani M, Samzadeh M, Narouie B, Jamaldini SH, Afshari M, Safavi
M, Roshandel MR, Hasanzad M. Genetic polymorphism of MMP2 gene and susceptibility to
prostate cancer. Arch Med Res. 2015; 46(7): 546-550.
7. hiomi , emaître , D’Armiento , Oka a Y. Matri metallo roteina e a i integrin an
metalloproteinasesand a disintegrin and metalloproteinases with thrombospondin motifs in
non-neoplastic diseases. Pathol Int. 2010; 60(7): 477-496.
8. Ebadi M, Yaghobi R, Geramizadeh B, Bahmani MK, Malek-Hosseini SA, Nemayandeh M.
Prevalence of HCV and HGV infections in Iranian liver transplant recipients. Transplant Proc.
2011; 43(2): 618-620.
9. Janfeshan S, Yaghobi R, Eidi A, Karimi MH, Geramizadeh B, Malekhosseini SA, Kafilzadeh F.
Expression profile of interferon regulatory factor 1 in chronic hepatitis B virus-infected liver
transplant patient. Exp Clin Transplant. 2017; 15(6): 669-675.
10. Zare A, Karimi MH, Rashki A, Geramizadeh B, Afshari A, Miri HR, Yaghobi R. Association of
the interleukin-27 gene expression and hepatitis B virus infection in liver transplanted patients.
Exp Clin Transplant. 2017; 15(5): 554-560
11. Yang HK, Jeong KC, Kim YK, Jung ST. Role of matrix metalloproteinase (MMP) 2 and MMP-9
in soft tissue sarcoma. Clin Orthop Surg. 2014; 6(4): 443-454.
12. Afshari A, Yaghobi R, Karimi MH, Darbouy M, Azarpira N, Geramizadeh B, Malek-Hosseini
SA, Nikeghbalian S. IL-17 mRNA expression and cytomegalovirus infection in liver transplant
patients. Exp Clin Transplant. 2015; 13(1): 83-89.
13. Chen G, Qin Dang YW, Yang J. The prospective role of matrix metalloproteinase-2/9 and
transforming growth factor beta 1 in accelerating the progression of hepatocellular carcinoma.
Translat Cancer Res. 2017; 6(1): 229-231.
14. Abdel-Latif MS. Plasma Levels of matrix metalloproteinase (MMP)-2, MMP-9 and tumor
necrosis factor-α in chronic hepatitis C virus patients. Open Microbiol J. 2015; 9:136-140.
15. Akca G, Tuncbilek S, Sepici-Dincel A. Association between matrix metalloproteinase (MMP)-2,
MMP-9 and total antioxidant status of patients with asymptomatic hepatitis C virus infection. Lett
Appl Microbiol. 2013; 57: 436-442.
16. Liang B, Li Y, Zhao A, Xie F, Guo Z. Clinical utility of serum matrix metalloproteinase-2 and
tissue inhibitor of metalloproteinase-2 concentrations in the assessment of liver fibrosis due to
chronic hepatitis B. J Int Med Res. 2012; 40: 631-639.
17. Łuka zewicz- ając M, Mroczko B, uziń ka-Ustymowicz K, Pryczynicz A, Gryko M, Kemona
A, Kę ra B, zmitkow ki M. Matri metallo roteina e 2 (MMP-2) and their tissue inhibitor 2
(TIMP-2) in gastric cancer patients. Adv Med Sci. 2013; 58(2): 235-243.
18. Jin Z, Sun R, Wei H, Gao X, Chen Y, Tian Z. Accelerated liver fibrosis in hepatitis B virus
transgenic mice: involvement of natural killer T cells. Hepatol. 2011; 53(1): 219-229.
19. Prystupa A, Boguszewska-Czubara A, Bojarska- unak A, oruń- urkow ka A, Roliń ki ,
ału ka W. Activity of MMP-2, MMP-8 and MMP-9 in serum as a marker of progression of
alcoholic liver disease in people from Lublin Region, eastern Poland. Ann Agric Environ Med.
2015; 22(2): 325-328.
20. Fioruci-Fontanelli BA, Chuffa LGA, Mendes LO, Pinheiro PFF, Delella FK, Kurokawa CS,
Felisbino SL, Martinez FE. MMP-2 and MMP-9 activities and TIMP-1 and TIMP-2 expression in
the prostatic tissue of two ethanol-preferring rat models. Anal Cell Pathol. 2015; 1: 1-7.
21. Madro A, Czechowska G, Slomka M, Celinski K, Szymonik-Lesiuk S, Kurzepa J. The decrease
of serum MMP-2 activity corresponds to alcoholic cirrhosis stage. Alcohol. 2012; 46(2): 155-1
|
